{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T01:44:32Z","timestamp":1773107072165,"version":"3.50.1"},"reference-count":119,"publisher":"Spandidos Publications","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2025.15279","type":"journal-article","created":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T11:33:29Z","timestamp":1758195209000},"page":"1-13","source":"Crossref","is-referenced-by-count":2,"title":["Discoidin domain receptor tyrosine kinase 2: A new perspective on microenvironment remodeling and targeted therapy of solid tumors (Review)"],"prefix":"10.3892","volume":"30","author":[{"given":"Tong","family":"Lu","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, The Second Hospital and Clinical Medical School, Lanzhou University, Lanzhou, Gansu 730000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huiying","family":"Guo","sequence":"additional","affiliation":[{"name":"Emergency Intensive Care Unit, Jining No. 1 People's Hospital, Jining, Shandong 272000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hang","family":"Gong","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, The Second Hospital and Clinical Medical School, Lanzhou University, Lanzhou, Gansu 730000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaohui","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, The Second Hospital and Clinical Medical School, Lanzhou University, Lanzhou, Gansu 730000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yonggang","family":"Tian","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, The Second Hospital and Clinical Medical School, Lanzhou University, Lanzhou, Gansu 730000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dekui","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, The Second Hospital and Clinical Medical School, Lanzhou University, Lanzhou, Gansu 730000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2025,9,18]]},"reference":[{"key":"key20251007110411_b1-ol-30-5-15279","doi-asserted-by":"publisher","first-page":"1331641","DOI":"10.3389\/fimmu.2024.1331641","article-title":"The roles of epigallocatechin gallate in the tumor microenvironment, metabolic reprogramming, and immunotherapy","volume":"15","author":"Li","year":"2024","journal-title":"Front Immunol"},{"key":"key20251007110411_b2-ol-30-5-15279","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"key20251007110411_b3-ol-30-5-15279","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.mcna.2023.06.002","article-title":"Cancer screening: Patient and population strategies","volume":"107","author":"Lane","year":"2023","journal-title":"Med Clin North Am"},{"key":"key20251007110411_b4-ol-30-5-15279","first-page":"100845","article-title":"Gastric cancer-Epidemiology, modifiable and non-modifiable risk factors, challenges and opportunities: An updated review","volume":"41","author":"Mamun","year":"2024","journal-title":"Cancer Treat Res Commun"},{"key":"key20251007110411_b5-ol-30-5-15279","first-page":"e64564","article-title":"Epidemiology of colorectal cancer in Saudi Arabia: A review","volume":"16","author":"Alessa","year":"2024","journal-title":"Cureus"},{"key":"key20251007110411_b6-ol-30-5-15279","doi-asserted-by":"publisher","first-page":"83","DOI":"10.5604\/01.3001.0054.4523","article-title":"Esophageal cancer: Current status and new insights from inflammatory markers-a brief review","volume":"96","author":"Strzelec","year":"2024","journal-title":"Pol Przegl Chir"},{"key":"key20251007110411_b7-ol-30-5-15279","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1007\/s11684-023-1050-6","article-title":"Improving the prognosis of pancreatic cancer: Insights from epidemiology, genomic alterations, and therapeutic challenges","volume":"17","author":"Liang","year":"2023","journal-title":"Front Med"},{"key":"key20251007110411_b8-ol-30-5-15279","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/s41571-024-00881-3","article-title":"Global epidemiology of epithelial ovarian cancer","volume":"21","author":"Webb","year":"2024","journal-title":"Nat Rev Clin Oncol"},{"key":"key20251007110411_b9-ol-30-5-15279","doi-asserted-by":"publisher","first-page":"110155","DOI":"10.1016\/j.isci.2024.110155","article-title":"Androgens in cervical cancer: Their role in epidemiology and biology","volume":"27","author":"Gu","year":"2024","journal-title":"iScience"},{"key":"key20251007110411_b10-ol-30-5-15279","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1093\/ndt\/gfae036","article-title":"Global epidemiology of kidney cancer","volume":"39","author":"Cirillo","year":"2024","journal-title":"Nephrol Dial Transplant"},{"key":"key20251007110411_b11-ol-30-5-15279","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.clbc.2023.04.004","article-title":"Metaplastic breast cancer: Current understanding and future directions","volume":"23","author":"Thomas","year":"2023","journal-title":"Clin Breast Cancer"},{"key":"key20251007110411_b12-ol-30-5-15279","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.thorsurg.2023.03.003","article-title":"Access to lung cancer screening","volume":"33","author":"Hasson","year":"2023","journal-title":"Thorac Surg Clin"},{"key":"key20251007110411_b13-ol-30-5-15279","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.eururo.2019.08.005","article-title":"Recent global patterns in prostate cancer incidence and mortality rates","volume":"77","author":"Culp","year":"2020","journal-title":"Eur Urol"},{"key":"key20251007110411_b14-ol-30-5-15279","doi-asserted-by":"publisher","first-page":"188928","DOI":"10.1016\/j.bbcan.2023.188928","article-title":"Molecular basis and targeted therapy in thyroid cancer: Progress and opportunities","volume":"1878","author":"Zhang","year":"2023","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"key20251007110411_b15-ol-30-5-15279","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s12967-023-03960-8","article-title":"Liquid biopsies: The future of cancer early detection","volume":"21","author":"Connal","year":"2023","journal-title":"J Transl Med"},{"key":"key20251007110411_b16-ol-30-5-15279","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/s41392-024-01823-2","article-title":"Tumor biomarkers for diagnosis, prognosis and targeted therapy","volume":"9","author":"Zhou","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"key20251007110411_b17-ol-30-5-15279","doi-asserted-by":"publisher","first-page":"e154943","DOI":"10.1172\/JCI154943","article-title":"Targeting mutations in cancer","volume":"132","author":"Waarts","year":"2022","journal-title":"J Clin Invest"},{"key":"key20251007110411_b18-ol-30-5-15279","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1016\/j.cell.2024.02.041","article-title":"Cancer biomarkers: Emerging trends and clinical implications for personalized treatment","volume":"187","author":"Passaro","year":"2024","journal-title":"Cell"},{"key":"key20251007110411_b19-ol-30-5-15279","doi-asserted-by":"publisher","first-page":"120669","DOI":"10.1016\/j.talanta.2019.120669","article-title":"Progress in cancer biomarkers monitoring strategies using graphene modified support materials","volume":"210","author":"Zaidi","year":"2020","journal-title":"Talanta"},{"key":"key20251007110411_b20-ol-30-5-15279","doi-asserted-by":"publisher","first-page":"747314","DOI":"10.3389\/fcell.2021.747314","article-title":"Recent advances in the role of discoidin domain receptor tyrosine kinase 1 and discoidin domain receptor tyrosine kinase 2 in breast and ovarian cancer","volume":"9","author":"Chen","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"key20251007110411_b21-ol-30-5-15279","doi-asserted-by":"publisher","first-page":"118496","DOI":"10.1016\/j.bbamcr.2019.06.010","article-title":"Discoidin domain receptors: Micro insights into macro assemblies","volume":"1866","author":"Agarwal","year":"2019","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"key20251007110411_b22-ol-30-5-15279","doi-asserted-by":"publisher","first-page":"6535","DOI":"10.3390\/ijms22126535","article-title":"The Journey of DDR1 and DDR2 kinase inhibitors as rising stars in the fight against cancer","volume":"22","author":"Elkamhawy","year":"2021","journal-title":"Int J Mol Sci"},{"key":"key20251007110411_b23-ol-30-5-15279","doi-asserted-by":"publisher","first-page":"14895","DOI":"10.3390\/ijms241914895","article-title":"Exploring the cellular and molecular mechanism of discoidin domain receptors (DDR1 and DDR2) in bone formation, regeneration, and its associated disease conditions","volume":"24","author":"Mariadoss","year":"2023","journal-title":"Int J Mol Sci"},{"key":"key20251007110411_b24-ol-30-5-15279","doi-asserted-by":"publisher","first-page":"102273","DOI":"10.1016\/j.ceb.2023.102273","article-title":"Novel roles for cooperating collagen receptor families in fibrotic niches","volume":"85","author":"Zeltz","year":"2023","journal-title":"Curr Opin Cell Biol"},{"key":"key20251007110411_b25-ol-30-5-15279","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1111\/cas.14789","article-title":"Discoidin domain receptors orchestrate cancer progression: A focus on cancer therapies","volume":"112","author":"Gao","year":"2021","journal-title":"Cancer Sci"},{"key":"key20251007110411_b26-ol-30-5-15279","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1534\/genetics.119.302492","article-title":"N-Glycosylation of the Discoidin domain receptor is required for axon regeneration in caenorhabditis elegans","volume":"213","author":"Shimizu","year":"2019","journal-title":"Genetics"},{"key":"key20251007110411_b27-ol-30-5-15279","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1172\/JCI200112373","article-title":"DDR2 receptor promotes MMP-2-mediated proliferation and invasion by hepatic stellate cells","volume":"108","author":"Olaso","year":"2001","journal-title":"J Clin Invest"},{"key":"key20251007110411_b28-ol-30-5-15279","doi-asserted-by":"publisher","first-page":"4506","DOI":"10.3390\/ijms20184506","article-title":"The role of MMP8 in cancer: A systematic review","volume":"20","author":"Juurikka","year":"2019","journal-title":"Int J Mol Sci"},{"key":"key20251007110411_b29-ol-30-5-15279","doi-asserted-by":"publisher","first-page":"1123638","DOI":"10.3389\/fonc.2023.1123638","article-title":"Focusing on discoidin domain receptors in premalignant and malignant liver diseases","volume":"13","author":"Gong","year":"2023","journal-title":"Front Oncol"},{"key":"key20251007110411_b30-ol-30-5-15279","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1158\/1541-7786.MCR-23-0347","article-title":"Stromal DDR2 promotes ovarian cancer metastasis through regulation of metabolism and secretion of extracellular matrix proteins","volume":"21","author":"Schab","year":"2023","journal-title":"Mol Cancer Res"},{"key":"key20251007110411_b31-ol-30-5-15279","doi-asserted-by":"publisher","first-page":"3385","DOI":"10.1007\/s00432-022-04110-1","article-title":"Co-expression of DDR2 and IFITM1 promotes breast cancer cell proliferation, migration and invasion and inhibits apoptosis","volume":"148","author":"Wu","year":"2022","journal-title":"J Cancer Res Clin Oncol"},{"key":"key20251007110411_b32-ol-30-5-15279","doi-asserted-by":"publisher","first-page":"e0200633","DOI":"10.1371\/journal.pone.0200633","article-title":"Distribution of KRAS, DDR2, and TP53 gene mutations in lung cancer: An analysis of Iranian patients","volume":"13","author":"Fathi","year":"2018","journal-title":"PLoS One"},{"key":"key20251007110411_b33-ol-30-5-15279","first-page":"e920020","article-title":"Knockdown of long non-coding RNA (lncRNA) Colon cancer-associated transcript-1 (CCAT1) suppresses oral squamous cell carcinoma proliferation, invasion, and migration by inhibiting the discoidin domain receptor 2 (DDR2)\/ERK\/AKT Axis","volume":"26","author":"Sun","year":"2020","journal-title":"Med Sci Monit"},{"key":"key20251007110411_b34-ol-30-5-15279","doi-asserted-by":"publisher","first-page":"264","DOI":"10.5694\/mja2.52227","article-title":"Screening and prevention of ovarian cancer","volume":"220","author":"Sideris","year":"2024","journal-title":"Med J Aust"},{"key":"key20251007110411_b35-ol-30-5-15279","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1038\/s41571-023-00819-1","article-title":"Heterogeneity and treatment landscape of ovarian carcinoma","volume":"20","author":"Veneziani","year":"2023","journal-title":"Nat Rev Clin Oncol"},{"key":"key20251007110411_b36-ol-30-5-15279","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1158\/1541-7786.MCR-23-0347","article-title":"Stromal DDR2 promotes ovarian cancer metastasis through regulation of metabolism and secretion of extracellular matrix proteins","volume":"21","author":"Schab","year":"2023","journal-title":"Mol Cancer Res"},{"key":"key20251007110411_b37-ol-30-5-15279","doi-asserted-by":"publisher","first-page":"1323115","DOI":"10.3389\/fimmu.2023.1323115","article-title":"A bibliometric and visual analysis of cancer-associated fibroblasts","volume":"14","author":"Yuan","year":"2023","journal-title":"Front Immunol"},{"key":"key20251007110411_b38-ol-30-5-15279","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/s41388-023-02884-3","article-title":"DDR2-regulated arginase activity in ovarian cancer-associated fibroblasts promotes collagen production and tumor progression","volume":"43","author":"Akinjiyan","year":"2024","journal-title":"Oncogene"},{"key":"key20251007110411_b39-ol-30-5-15279","doi-asserted-by":"publisher","first-page":"2659","DOI":"10.1038\/s41388-023-02793-5","article-title":"Microenvironmental Snail1-induced immunosuppression promotes melanoma growth","volume":"42","author":"Arumi-Planas","year":"2023","journal-title":"Oncogene"},{"key":"key20251007110411_b40-ol-30-5-15279","first-page":"55","article-title":"Snail1-driven plasticity of epithelial and mesenchymal cells sustains cancer malignancy","volume":"1856","author":"Baulida","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"key20251007110411_b41-ol-30-5-15279","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.ejphar.2014.07.025","article-title":"Cisplatin in cancer therapy: Molecular mechanisms of action","volume":"740","author":"Dasari","year":"2014","journal-title":"Eur J Pharmacol"},{"key":"key20251007110411_b42-ol-30-5-15279","doi-asserted-by":"publisher","first-page":"100938","DOI":"10.1016\/j.drup.2023.100938","article-title":"Regulation of cisplatin resistance in bladder cancer by epigenetic mechanisms","volume":"68","author":"Li","year":"2023","journal-title":"Drug Resist Updat"},{"key":"key20251007110411_b43-ol-30-5-15279","doi-asserted-by":"publisher","first-page":"4855","DOI":"10.3390\/cancers13194855","article-title":"Heat shock protein 27, a novel downstream target of collagen type XI alpha 1, synergizes with fatty acid oxidation to confer cisplatin resistance in ovarian cancer cells","volume":"13","author":"Heiserman","year":"2021","journal-title":"Cancers (Basel)"},{"key":"key20251007110411_b44-ol-30-5-15279","doi-asserted-by":"publisher","first-page":"7208","DOI":"10.3390\/ijms25137208","article-title":"Breast cancer treatment strategies targeting the tumor microenvironment: How to Convert \u2018Cold\u2019 Tumors to \u2018Hot\u2019 Tumors","volume":"25","author":"Yang","year":"2024","journal-title":"Int J Mol Sci"},{"key":"key20251007110411_b45-ol-30-5-15279","doi-asserted-by":"publisher","first-page":"2510","DOI":"10.1016\/j.celrep.2016.05.033","article-title":"The action of discoidin domain receptor 2 in basal tumor cells and stromal Cancer-associated fibroblasts is critical for breast cancer metastasis","volume":"15","author":"Corsa","year":"2016","journal-title":"Cell Rep"},{"key":"key20251007110411_b46-ol-30-5-15279","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1038\/s41388-021-01676-x","article-title":"DDR2 upregulation confers ferroptosis susceptibility of recurrent breast tumors through the Hippo pathway","volume":"40","author":"Lin","year":"2021","journal-title":"Oncogene"},{"key":"key20251007110411_b47-ol-30-5-15279","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41392-024-01769-5","article-title":"Ferroptosis in cancer: From molecular mechanisms to therapeutic strategies","volume":"9","author":"Zhou","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"key20251007110411_b48-ol-30-5-15279","doi-asserted-by":"publisher","first-page":"1244781","DOI":"10.3389\/fonc.2023.1244781","article-title":"Triple-negative breast cancer: From none to multiple therapeutic targets in two decades","volume":"13","author":"Carvalho","year":"2023","journal-title":"Front Oncol"},{"key":"key20251007110411_b49-ol-30-5-15279","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.3390\/diagnostics14171875","article-title":"Triple-negative breast cancer: Molecular particularities still a challenge","volume":"14","author":"Varzaru","year":"2024","journal-title":"Diagnostics (Basel)"},{"key":"key20251007110411_b50-ol-30-5-15279","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s10549-015-3285-7","article-title":"Tyrosine kinase discoidin domain receptors DDR1 and DDR2 are coordinately deregulated in triple-negative breast cancer","volume":"150","author":"Toy","year":"2015","journal-title":"Breast Cancer Res Treat"},{"key":"key20251007110411_b51-ol-30-5-15279","doi-asserted-by":"publisher","first-page":"2828","DOI":"10.3390\/cells11182828","article-title":"Targeting gastric cancer stem cells to enhance treatment response","volume":"11","author":"Rao","year":"2022","journal-title":"Cells"},{"key":"key20251007110411_b52-ol-30-5-15279","doi-asserted-by":"publisher","first-page":"104601","DOI":"10.1016\/j.ebiom.2023.104601","article-title":"Towards an optimal model for gastric cancer peritoneal metastasis: Current challenges and future directions","volume":"92","author":"Li","year":"2023","journal-title":"EBioMedicine"},{"key":"key20251007110411_b53-ol-30-5-15279","doi-asserted-by":"publisher","first-page":"57","DOI":"10.21037\/tgh.2020.02.08","article-title":"Molecular biology and immunology of gastric cancer peritoneal metastasis","volume":"5","author":"Yao","year":"2020","journal-title":"Transl Gastroenterol Hepatol"},{"key":"key20251007110411_b54-ol-30-5-15279","doi-asserted-by":"publisher","first-page":"22371","DOI":"10.1038\/srep22371","article-title":"Integrated molecular profiling of human gastric cancer identifies DDR2 as a potential regulator of peritoneal dissemination","volume":"6","author":"Kurashige","year":"2016","journal-title":"Sci Rep"},{"key":"key20251007110411_b55-ol-30-5-15279","doi-asserted-by":"publisher","first-page":"2272","DOI":"10.1007\/s10620-016-4116-3","article-title":"DDR2 induces gastric cancer cell activities via activating mTORC2 signaling and is associated with clinicopathological characteristics of gastric cancer","volume":"61","author":"Wang","year":"2016","journal-title":"Dig Dis Sci"},{"key":"key20251007110411_b56-ol-30-5-15279","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1002\/cbf.3889","article-title":"Impact of curcumin on ferroptosis-related genes in colorectal cancer: Insights from in-silico and in-vitro studies","volume":"41","author":"Firouzjaei","year":"2023","journal-title":"Cell Biochem Funct"},{"key":"key20251007110411_b57-ol-30-5-15279","doi-asserted-by":"publisher","first-page":"101993","DOI":"10.1016\/j.suronc.2023.101993","article-title":"A review of targeted therapy and immune checkpoint inhibitors for metastatic colorectal cancer","volume":"51","author":"Ruff","year":"2023","journal-title":"Surg Oncol"},{"key":"key20251007110411_b58-ol-30-5-15279","doi-asserted-by":"publisher","first-page":"125","DOI":"10.3389\/fonc.2020.00125","article-title":"Collagen kinase receptors as potential therapeutic targets in metastatic colon cancer","volume":"10","author":"Lafitte","year":"2020","journal-title":"Front Oncol"},{"key":"key20251007110411_b59-ol-30-5-15279","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s12307-011-0074-7","article-title":"The colorectal tumor microenvironment: The next decade","volume":"4","author":"Beauchemin","year":"2011","journal-title":"Cancer Microenviron"},{"key":"key20251007110411_b60-ol-30-5-15279","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1002\/ijc.34227","article-title":"Special issue \u2018The advance of solid tumor research in China\u2019: Discoidin domain receptor 2 promotes colorectal cancer metastasis by regulating epithelial mesenchymal transition via activating AKT signaling","volume":"152","author":"Xu","year":"2023","journal-title":"Int J Cancer"},{"key":"key20251007110411_b61-ol-30-5-15279","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.acr.2020.10.001","article-title":"Hepatocellular carcinoma (HCC): Epidemiology, etiology and molecular classification","volume":"149","author":"Chidambaranathan-Reghupaty","year":"2021","journal-title":"Adv Cancer Res"},{"key":"key20251007110411_b62-ol-30-5-15279","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.3390\/cells9061370","article-title":"Biomarkers in hepatocellular carcinoma: Diagnosis, prognosis and treatment response assessment","volume":"9","author":"Pi\u00f1ero","year":"2020","journal-title":"Cells"},{"key":"key20251007110411_b63-ol-30-5-15279","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.2147\/IJGM.S348110","article-title":"Discoidin domain receptor 1, a potential biomarker and therapeutic target in hepatocellular carcinoma","volume":"15","author":"Wu","year":"2022","journal-title":"Int J Gen Med"},{"key":"key20251007110411_b64-ol-30-5-15279","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1007\/s00432-015-1967-5","article-title":"Downregulation of discoidin domain receptor 2 decreases tumor growth of hepatocellular carcinoma","volume":"141","author":"Park","year":"2015","journal-title":"J Cancer Res Clin Oncol"},{"key":"key20251007110411_b65-ol-30-5-15279","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s13046-015-0218-6","article-title":"DDR2 facilitates hepatocellular carcinoma invasion and metastasis via activating ERK signaling and stabilizing SNAIL1","volume":"34","author":"Xie","year":"2015","journal-title":"J Exp Clin Cancer Res"},{"key":"key20251007110411_b66-ol-30-5-15279","doi-asserted-by":"publisher","first-page":"964442","DOI":"10.3389\/fimmu.2022.964442","article-title":"The role of PD-1\/PD-L1 and application of immune-checkpoint inhibitors in human cancers","volume":"13","author":"Tang","year":"2022","journal-title":"Front Immunol"},{"key":"key20251007110411_b67-ol-30-5-15279","doi-asserted-by":"publisher","first-page":"1323581","DOI":"10.3389\/fimmu.2023.1323581","article-title":"The current status and future of PD-L1 in liver cancer","volume":"14","author":"Hao","year":"2023","journal-title":"Front Immunol"},{"key":"key20251007110411_b68-ol-30-5-15279","first-page":"2595","article-title":"Role and mechanism of programmed death-ligand 1 in hypoxia-induced liver cancer immune escape","volume":"19","author":"Wen","year":"2020","journal-title":"Oncol Lett"},{"key":"key20251007110411_b69-ol-30-5-15279","doi-asserted-by":"publisher","first-page":"3269","DOI":"10.1007\/s00415-020-09942-w","article-title":"Oxaliplatin-induced peripheral neuropathy: Clinical features, mechanisms, prevention and treatment","volume":"268","author":"Kang","year":"2021","journal-title":"J Neurol"},{"key":"key20251007110411_b70-ol-30-5-15279","doi-asserted-by":"publisher","first-page":"101377","DOI":"10.1016\/j.jcmgh.2024.101377","article-title":"DDR2\/STAT3 positive feedback loop mediates the immunosuppressive microenvironment by upregulating PD-L1 and recruiting MDSCs in Oxaliplatin-resistant HCC","volume":"18","author":"Liu","year":"2024","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"key20251007110411_b71-ol-30-5-15279","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/s41392-021-00670-9","article-title":"Myeloid-derived suppressor cells as immunosuppressive regulators and therapeutic targets in cancer","volume":"6","author":"Li","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"key20251007110411_b72-ol-30-5-15279","doi-asserted-by":"publisher","first-page":"175913","DOI":"10.1016\/j.ejphar.2023.175913","article-title":"Understanding sorafenib-induced ferroptosis and resistance mechanisms: Implications for cancer therapy","volume":"955","author":"Li","year":"2023","journal-title":"Eur J Pharmacol"},{"key":"key20251007110411_b73-ol-30-5-15279","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/s41392-020-0187-x","article-title":"The mechanisms of sorafenib resistance in hepatocellular carcinoma: Theoretical basis and therapeutic aspects","volume":"5","author":"Tang","year":"2020","journal-title":"Signal Transduct Target Ther"},{"key":"key20251007110411_b74-ol-30-5-15279","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1002\/cbin.11625","article-title":"Amplification of DDR2 mediates sorafenib resistance through NF-\u03baB\/c-Rel signaling in hepatocellular carcinoma","volume":"45","author":"Liu","year":"2021","journal-title":"Cell Biol Int"},{"key":"key20251007110411_b75-ol-30-5-15279","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1186\/s13046-022-02544-6","article-title":"LncRNA CEBPA-DT promotes liver cancer metastasis through DDR2\/\u03b2-catenin activation via interacting with hnRNPC","volume":"41","author":"Cai","year":"2022","journal-title":"J Exp Clin Cancer Res"},{"key":"key20251007110411_b76-ol-30-5-15279","doi-asserted-by":"publisher","first-page":"e28473","DOI":"10.1002\/pbc.28473","article-title":"Neuroblastoma","volume":"68","author":"Chung","year":"2021","journal-title":"Pediatr Blood Cancer"},{"key":"key20251007110411_b77-ol-30-5-15279","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1002\/2211-5463.13798","article-title":"DDR2 signaling and mechanosensing orchestrate neuroblastoma cell fate through different transcriptome mechanisms","volume":"14","author":"Vessella","year":"2024","journal-title":"FEBS Open Bio"},{"key":"key20251007110411_b78-ol-30-5-15279","doi-asserted-by":"publisher","first-page":"2684","DOI":"10.1038\/s41467-023-38342-7","article-title":"Phase II trial of neoadjuvant sitravatinib plus nivolumab in patients undergoing nephrectomy for locally advanced clear cell renal cell carcinoma","volume":"14","author":"Karam","year":"2023","journal-title":"Nat Commun"},{"key":"key20251007110411_b79-ol-30-5-15279","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1158\/1535-7163.MCT-23-0741","article-title":"Blockade of discoidin domain receptor signaling with sitravatinib reveals DDR2 as a mediator of neuroblastoma pathogenesis and metastasis","volume":"23","author":"Rozen","year":"2024","journal-title":"Mol Cancer Ther"},{"key":"key20251007110411_b80-ol-30-5-15279","doi-asserted-by":"publisher","first-page":"e389708","DOI":"10.1200\/EDBK_389708","article-title":"Management of advanced thyroid cancer: Overview, advances, and opportunities","volume":"43","author":"Agosto Salgado","year":"2023","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"key20251007110411_b81-ol-30-5-15279","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-0716-2505-7_1","article-title":"Papillary thyroid carcinoma: Current position in epidemiology, genomics, and classification","volume":"2534","author":"Lam","year":"2022","journal-title":"Methods Mol Biol"},{"key":"key20251007110411_b82-ol-30-5-15279","first-page":"8114","article-title":"DDR2 facilitates papillary thyroid carcinoma epithelial mesenchymal transition by activating ERK2\/Snail1 pathway","volume":"14","author":"Liang","year":"2017","journal-title":"Oncol Lett"},{"key":"key20251007110411_b83-ol-30-5-15279","first-page":"e70016","article-title":"Prostate cancer: A review of genetics, current biomarkers and personalised treatments","volume":"7","author":"Wilson","year":"2024","journal-title":"Cancer Rep (Hoboken)"},{"key":"key20251007110411_b84-ol-30-5-15279","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.1007\/s00261-019-02305-8","article-title":"Prostate cancer and the role of biomarkers","volume":"45","author":"Nevo","year":"2020","journal-title":"Abdom Radiol (NY)"},{"key":"key20251007110411_b85-ol-30-5-15279","first-page":"356","article-title":"Evaluation of discoidin domain receptor-2 (DDR2) expression level in normal, benign, and malignant human prostate tissues","volume":"10","author":"Azemikhah","year":"2015","journal-title":"Res Pharm Sci"},{"key":"key20251007110411_b86-ol-30-5-15279","doi-asserted-by":"publisher","first-page":"9599","DOI":"10.18632\/aging.205889","article-title":"Prognosis and diagnosis of prostate cancer based on hypergraph regularization sparse least partial squares regression algorithm","volume":"16","author":"Huang","year":"2024","journal-title":"Aging (Albany NY)"},{"key":"key20251007110411_b87-ol-30-5-15279","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1016\/j.bbadis.2014.04.018","article-title":"Discoidin domain receptor 2 facilitates prostate cancer bone metastasis via regulating parathyroid hormone-related protein","volume":"1842","author":"Yan","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"key20251007110411_b88-ol-30-5-15279","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/bcp.15504","article-title":"The evolving role of checkpoint inhibitors in the treatment of urothelial carcinoma","volume":"89","author":"Tang","year":"2023","journal-title":"Br J Clin Pharmacol"},{"key":"key20251007110411_b89-ol-30-5-15279","doi-asserted-by":"publisher","first-page":"78918","DOI":"10.18632\/oncotarget.12912","article-title":"DDR2 overexpression in urothelial carcinoma indicates an unfavorable prognosis: A large cohort study","volume":"7","author":"Tsai","year":"2016","journal-title":"Oncotarget"},{"key":"key20251007110411_b90-ol-30-5-15279","first-page":"386","article-title":"DDR1 and DDR2 in skin","volume":"12","author":"Cario","year":"2018","journal-title":"Cell Adh Migr"},{"key":"key20251007110411_b91-ol-30-5-15279","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.1038\/s41388-022-02266-1","article-title":"Discoidin domain receptor 2 orchestrates melanoma resistance combining phenotype switching and proliferation","volume":"41","author":"Sala","year":"2022","journal-title":"Oncogene"},{"key":"key20251007110411_b92-ol-30-5-15279","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1093\/abbs\/gmv005","article-title":"DDR2 inhibition reduces migration and invasion of murine metastatic melanoma cells by suppressing MMP2\/9 expression through ERK\/NF-\u03baB pathway","volume":"47","author":"Poudel","year":"2015","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"key20251007110411_b93-ol-30-5-15279","doi-asserted-by":"publisher","first-page":"107753","DOI":"10.1016\/j.pharmthera.2020.107753","article-title":"Tumor microenvironment as a therapeutic target in cancer","volume":"221","author":"Xiao","year":"2021","journal-title":"Pharmacol Ther"},{"key":"key20251007110411_b94-ol-30-5-15279","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1002\/biof.1776","article-title":"Targeting of the tumor microenvironment by curcumin","volume":"47","author":"Fu","year":"2021","journal-title":"Biofactors"},{"key":"key20251007110411_b95-ol-30-5-15279","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/s41392-021-00544-0","article-title":"Extracellular matrix and its therapeutic potential for cancer treatment","volume":"6","author":"Huang","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"key20251007110411_b96-ol-30-5-15279","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13045-022-01252-0","article-title":"Targeting extracellular matrix stiffness and mechanotransducers to improve cancer therapy","volume":"15","author":"Jiang","year":"2022","journal-title":"J Hematol Oncol"},{"key":"key20251007110411_b97-ol-30-5-15279","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12943-023-01744-8","article-title":"Extracellular matrix remodeling in tumor progression and immune escape: From mechanisms to treatments","volume":"22","author":"Yuan","year":"2023","journal-title":"Mol Cancer"},{"key":"key20251007110411_b98-ol-30-5-15279","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1158\/2159-8290.CD-24-0002","article-title":"The Interplay between extracellular matrix remodeling and cancer therapeutics","volume":"14","author":"Prakash","year":"2024","journal-title":"Cancer Discov"},{"key":"key20251007110411_b99-ol-30-5-15279","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.matbio.2013.12.002","article-title":"Discoidin domain receptors in disease","volume":"34","author":"Borza","year":"2014","journal-title":"Matrix Biol"},{"key":"key20251007110411_b100-ol-30-5-15279","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1038\/s41571-021-00546-5","article-title":"Clinical and therapeutic relevance of cancer-associated fibroblasts","volume":"18","author":"Chen","year":"2021","journal-title":"Nat Rev Clin Oncol"},{"key":"key20251007110411_b101-ol-30-5-15279","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s12943-023-01860-5","article-title":"Define cancer-associated fibroblasts (CAFs) in the tumor microenvironment: New opportunities in cancer immunotherapy and advances in clinical trials","volume":"22","author":"Zhang","year":"2023","journal-title":"Mol Cancer"},{"key":"key20251007110411_b102-ol-30-5-15279","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.3390\/cancers15061899","article-title":"Cancer-associated fibroblasts: Master tumor microenvironment modifiers","volume":"15","author":"Wright","year":"2023","journal-title":"Cancers (Basel)"},{"key":"key20251007110411_b103-ol-30-5-15279","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/cas.15609","article-title":"The heterogeneity of cancer-associated fibroblast subpopulations: Their origins, biomarkers, and roles in the tumor microenvironment","volume":"114","author":"Yamamoto","year":"2023","journal-title":"Cancer Sci"},{"key":"key20251007110411_b104-ol-30-5-15279","doi-asserted-by":"publisher","first-page":"3482","DOI":"10.3390\/cancers14143482","article-title":"DDR2 expression in Cancer-associated fibroblasts promotes ovarian cancer tumor invasion and metastasis through periostin-ITGB1","volume":"14","author":"Akinjiyan","year":"2022","journal-title":"Cancers (Basel)"},{"key":"key20251007110411_b105-ol-30-5-15279","doi-asserted-by":"publisher","first-page":"jcs258431","DOI":"10.1242\/jcs.258431","article-title":"Tyrosine kinase-independent actions of DDR2 in tumor cells and cancer-associated fibroblasts influence tumor invasion, migration and metastasis","volume":"134","author":"Barcus","year":"2021","journal-title":"J Cell Sci"},{"key":"key20251007110411_b106-ol-30-5-15279","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1038\/s41392-020-00449-4","article-title":"Advantages of targeting the tumor immune microenvironment over blocking immune checkpoint in cancer immunotherapy","volume":"6","author":"Tang","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"key20251007110411_b107-ol-30-5-15279","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1038\/s41392-023-01522-4","article-title":"Immune checkpoint therapy for solid tumours: Clinical dilemmas and future trends","volume":"8","author":"Sun","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"key20251007110411_b108-ol-30-5-15279","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/s41568-022-00454-5","article-title":"Therapy resistance: Opportunities created by adaptive responses to targeted therapies in cancer","volume":"22","author":"Labrie","year":"2022","journal-title":"Nat Rev Cancer"},{"key":"key20251007110411_b109-ol-30-5-15279","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3389\/fphar.2016.00346","article-title":"Discoidin domain receptors: Potential actors and targets in cancer","volume":"7","author":"Rammal","year":"2016","journal-title":"Front Pharmacol"},{"key":"key20251007110411_b110-ol-30-5-15279","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.3389\/fonc.2020.01748","article-title":"Discoidin domain receptors in melanoma: Potential therapeutic targets to overcome MAPK inhibitor resistance","volume":"10","author":"Reger de Moura","year":"2020","journal-title":"Front Oncol"},{"key":"key20251007110411_b111-ol-30-5-15279","doi-asserted-by":"publisher","first-page":"844142","DOI":"10.3389\/fimmu.2022.844142","article-title":"Immunotherapy: Reshape the tumor immune microenvironment","volume":"13","author":"Lv","year":"2022","journal-title":"Front Immunol"},{"key":"key20251007110411_b112-ol-30-5-15279","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1146\/annurev-pathmechdis-051222-122423","article-title":"Update on Epithelial-Mesenchymal plasticity in cancer progression","volume":"19","author":"Fontana","year":"2024","journal-title":"Annu Rev Pathol"},{"key":"key20251007110411_b113-ol-30-5-15279","article-title":"Pharnexcloud Cloud database: CIDD-0108633"},{"key":"key20251007110411_b114-ol-30-5-15279","article-title":"Pharnexcloud Cloud database ICP-033"},{"key":"key20251007110411_b115-ol-30-5-15279","article-title":"Pharnexcloud Cloud database BK-40143"},{"key":"key20251007110411_b116-ol-30-5-15279","article-title":"Pharnexcloud Cloud database PB-1"},{"key":"key20251007110411_b117-ol-30-5-15279","article-title":"Pharnexcloud Cloud database Dual-DDR1\/2inhibitors"},{"key":"key20251007110411_b118-ol-30-5-15279","journal-title":"Dasatinib"},{"key":"key20251007110411_b119-ol-30-5-15279","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.matbio.2023.12.003","article-title":"Novel insights into the role of Discoidin domain receptor 2 (DDR2) in cancer progression: A new avenue of therapeutic intervention","volume":"125","author":"Trono","year":"2024","journal-title":"Matrix Biol"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T08:04:30Z","timestamp":1759824270000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2025.15279"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,18]]},"references-count":119,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,9,18]]}},"URL":"https:\/\/doi.org\/10.3892\/ol.2025.15279","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,18]]}}}